mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
Bryostatin 1 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
Bicalutamide |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |